 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
Luminex's 2013 Priorities Include GPP, NeoPlex Adoption, MagPix Placements, Project Aries
February 05, 2013
Luminex's 2013 Priorities Include GPP, NeoPlex Adoption, MagPix Placements, Project Aries
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Luminex to Target Smaller Clinical Labs with FDA-Cleared MagPix System, Gastro Pathogen Panel
April 16, 2013 / BioArray News - UPDATE: Luminex Gains FDA Clearance for Gastro Test; Expects Clearance for Newborn Test in H2
January 15, 2013 / BioArray News - Luminex Leveraging Advanced Liquid Logic Alliance to Develop Field-based MDx/Immunoassay System
May 16, 2013 / PCR Insider - Luminex, Posting Q1 Revenue Growth, Provides Updates on Gastro Pathogen, NeoPlex Assays
April 30, 2013 / BioArray News - Luminex Expects 2013 FDA Clearance for Gastro Pathogen Panel as Q3 Revenues Rise 10 Percent
October 30, 2012 / BioArray News